GlaxoSmithKline, Pfizer combine drugs in early melanoma study
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline is testing its recently approved cancer therapy Mekinist with Pfizer’s experimental drug palbociclib in an early study treating advanced melanoma patients.